ipafricept
Recombinant proteinexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2012 (NCT01608867)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Frizzled-8ANTAGONIST
FZD8 antagonist
mAB
- Frizzled-8INHIBITOR
FZD8 inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3301577 ↗
Also known as
- ipafricept
- ipafricept
- omp-54f28
- omp-54f28
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02069145 | Phase 1 | Jan 1, 2014 | Mereo BioPharma |
| NCT02092363 | Phase 1 | Jan 1, 2014 | Mereo BioPharma |
| NCT02050178 | Phase 1 | Nov 1, 2013 | Mereo BioPharma |
| NCT01608867 | Phase 1 | Jun 1, 2012 | Bayer, Mereo BioPharma |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mereo BioPharma | For profit | 4 | 4 | 1 | 2012 |
| Bayer | For profit | 1 | 0 | 1 | 2012 |
2 organizations
Page 1 / 1